Pu Huang

Typha angustifolia L.

Also known as: Cattail pollen(English) 蒲黄(Chinese)

Pohwang蒲黃 포황 Bồ hoàng P'u Huang

Updated October 23, 2026 · Not yet clinically reviewed

Pu Huang
William Curtis, 1777 · public domain, via Wikimedia Commons

Safety at a glance

High risk

Pregnancy: avoid — uterine stimulant (raw)

Caution

With warfarin, coumadin, anticoagulant: blood-moving herb (活血化瘀) → possible additive bleeding risk; no clinical evidence for the class

Caution

3 recorded drug interactions, 1 major or contraindicated

Note

Contraindications or side effects are listed

No rule in our tables for this herb: breastfeeding, incompatible pairs (十八反 / 十九畏), dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
regulating blood
Temperature
Neutral
Taste
Sweet
Channels
Liver,Pericardium

Functions

Stops Bleeding; Invigorates Blood and Dispels Stasis; Promotes Urination and Relieves Stranguria

Traditional uses

Pu Huang (cattail pollen) is a neutral-warm, astringent-sweet herb that both stops bleeding and invigorates Blood — making it appropriate for both hemorrhage and pain from Blood stagnation. Raw Pu Huang has a stronger Blood-moving effect for menstrual pain, traumatic injury, and Blood stasis conditions, while charred Pu Huang focuses on stopping bleeding from uterine hemorrhage, hematuria, and similar conditions. It is a primary hemostatic and Blood-moving herb frequently combined with Wu Ling Zhi in classical pain and bleeding formulas.

Western herbalism

Properties: astringent, diuretic

Traditional American uses

Native American tribes including the Pima, Hopi, Malecite, and Micmac used Typha angustifolia primarily as a fiber, food, and ceremonial plant. Documented medicinal (Drug) uses in the NAEB database are limited to kidney aid and urinary aid applications, employing the roots and rhizomes (NAEB).

Pharmacological effects

  • Coagulant: Decoction shortened human blood clotting in vitro; oral aqueous/alcoholic extracts shortened clotting time in rabbits; s.c. extract raised platelet count and cut prothrombin time; topical pollen stopped femoral arterial bleeding in dogs.
  • Cardiovascular: Alcoholic extract was biphasic on isolated toad heart and inhibitory at high doses; increased coronary flow in isolated rabbit hearts (more so under pituitrin constriction), raised myocardial 86Rb uptake in mice, increased femoral blood flow in dogs, and lowered blood pressure i.v. in cats, rabbits and dogs.
  • Hypocholesterolemic and antiatherosclerotic: In high-fat-fed rabbits (16 g/animal/day for 12 weeks plus 4 weeks), serum cholesterol and aortic/coronary atherosclerotic lesions were reduced, with increased fecal cholesterol and slower cholesterol absorption.
  • Uterine: Decoction, tincture and ether extract stimulated isolated uteri of guinea pigs, rats and mice (spastic contraction at large doses), more on non-pregnant uterus; alcoholic extract contracted isolated rabbit uterus.
  • Antiinflammatory: Topical concentrated decoction reduced scald edema in rats; i.p. decoction reduced egg-white paw edema and histamine-increased vascular permeability in rats and mice.
  • Intestinal: Extract enhanced peristalsis of isolated rabbit intestine and tone of rat/guinea pig duodenum (atropine-blockable); isorhamnetin was spasmolytic on mouse intestine at 57% the potency of papaverine.

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 429.

Formulas using this herb

11 of 11 formulas

Botanical

Typha angustifolia, narrowleaf cattail, is a perennial aquatic or semi-aquatic herb in the Typhaceae family, native to wetlands across temperate Eurasia and North America. It grows from creeping rhizomes to 1.5-3 m tall, with linear, flat to slightly convex leaves 3-12 mm wide. The diagnostic inflorescence is a dense cylindrical spike with a separated male (upper) portion above a thinner gap, then a slender brown female (lower) portion 10-30 cm long. In TCM, Pu Huang is the dried yellow pollen collected from male flowers in summer. Plants thrive in marshes, pond margins, and slow streams.

Family
Typhaceae
Pharmaceutical name
Pollen Typhae
Parts used
flower
Plant type
herb

Constituents

Typhaneoside

Flavonol triglycoside · one of the two principal flavonoid glycosides of the pollen and a Pharmacopoeia quality marker

Typhaneoside and isorhamnetin-3-O-neohesperidoside are identified as the main antinociceptive constituents of the pollen. Both are flavonol glycosides, and both are degraded when the pollen is stir-fried to charcoal, which is the chemical basis for the raw versus charred distinction in dispensing.

Isorhamnetin-3-O-neohesperidoside

Flavonol glycoside · the other principal flavonoid glycoside of the pollen, alongside typhaneoside

Reported with typhaneoside as one of the main antinociceptive compounds of Pu Huang, consistent with the traditional use of the raw pollen for dysmenorrhoea and stasis pain rather than purely for bleeding.

Flavonol aglycones (quercetin, kaempferol, isorhamnetin)

Flavonol aglycones · total flavonoids of a water extract measured at 31.5 mg/g with total phenolics at 32.6 mg/g; the average content of these three aglycones rises about 30 percent on carbonisation

These are the compounds that carbonisation creates at the expense of the glycosides, and the compounds that separate the haemostatic charred drug from the stasis-moving raw drug. A spectrum-activity study comparing raw and carbonised Typha angustifolia found the difference in thrombin activity tracked chiefly with quercetin and isorhamnetin. Two carbon-derived compounds, huaicarbon A and B, are detectable only in the carbonised product.

Acidic (pectin-type) polysaccharide

Polysaccharide · the DEAE-adsorbed acidic fraction of the aqueous pollen extract

This is the fraction responsible for topical haemostasis. It directly activates coagulation factor XII, an effect attributed to its electronegative charge, and the whole pollen extract shortens prothrombin time, activated partial thromboplastin time and recalcification time in vitro. Notably the acidic polysaccharide fraction did NOT shorten bleeding when given orally in the mouse tail model, so the external and internal actions of this drug rest on different constituents.

Drug interactions

Warfarin, DOACs and antiplatelet drugs

Moderate · Unpredictable - the drug has both procoagulant and anticoagulant constituents and the net direction depends on route and on whether the pollen is raw or charred · Evidence level: Possible

Pu Huang is genuinely two-directional and should not be filed simply as a bleeding risk. Its acidic polysaccharide activates factor XII and shortens clotting times in vitro, and the carbonised pollen enhances haemostasis, which would oppose anticoagulation. Its flavonoids, however, carry anticoagulant and fibrinolytic activity, and reviews of the raw drug report slowed platelet aggregation, reduced prothrombin, thrombin and activated partial thromboplastin times and reduced serum fibrinogen, with reduced platelet intracellular calcium and PI3K/Akt/eNOS signalling proposed as mechanisms. The mouse tail-bleeding work showed the oral effect is carried by constituents other than the polysaccharide.

Clinical note: In an anticoagulated patient, treat any change of Pu Huang - starting it, stopping it, or switching between raw and charred stock - as a reason to recheck the INR or coagulation status. Do not assume the direction of the change.

Pregnancy (uterine stimulant)

Major · Uterine contraction; risk of pregnancy loss · Evidence level: Probable

Pollen Typhae extract increases muscle tension and prolongs the contraction time of isolated rat uterine smooth muscle, which is the pharmacological counterpart of the classical contraindication in pregnancy and of the drug's use for postpartum abdominal pain and retained lochia.

Clinical note: Contraindicated in pregnancy. It remains appropriate postpartum, which is where the classical texts place it.

Raw versus charred Pu Huang (Pu Huang Tan) dispensed interchangeably

Moderate · The opposite pharmacological action to the one intended is given · Evidence level: Established

Stir-frying to charcoal is not a cosmetic processing step here. UPLC-QTOF-MS comparison of raw and carbonised Typhae Pollen found flavonoid glycoside content significantly reduced and the three flavonol aglycones increased about 30 percent, with two carbonisation products detectable only in the charred drug. Functionally, in zebrafish models the raw pollen promoted angiogenesis by upregulating VEGFA, flt1 and kdr, while carbonisation lost that pro-angiogenic activity and gained haemostatic activity via upregulation of VEGFA and von Willebrand factor. Six chemical markers now exist to tell the two apart.

Clinical note: Specify raw or charred on the prescription and check what was actually supplied. Raw Pu Huang for stasis pain and dysmenorrhoea, Pu Huang Tan for active bleeding - substituting one for the other works against the treatment aim.

Dosage

FormAmountFrequencyNotes
decoction5–10 gDaily
中国药典 2020 【用法与用量】5~10g,包煎。外用适量,敷患处。 【注意】孕妇慎用。 【性味与归经】甘,平。归肝、心包经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value.

Dui yao: classical pairings

Pu Huang + Wu Ling Zhi五灵脂

The combination both invigorates blood and stops bleeding, dispelling stasis to relieve pain without leaving bleeding unchecked.

Blood-stasis pain of the chest and abdomen, dysmenorrhea and retained lochia. Wu Ling Zhi is traditionally listed as antagonising Ren Shen (Shi Jiu Wei). Avoid in pregnancy.

Core pair of a classical formula — Shi Xiao San, Tai Ping Hui Min He Ji Ju Fang

Evidence

Study design on record, not certainty of outcome.

In vitro / animal
4

Experimental study on the hemostatc activity of Pollen Typhae

Ohkura N, Tamura K, Tanaka A, Matsuda J, Atsumi G · Blood Coagulation & Fibrinolysis · 2011 · animal

In vitro / animal · Not yet verified

Pollen extract shortened prothrombin time, activated partial thromboplastin time and recalcification time, and directly activated factor XII; the active agent was the acidic polysaccharide retained on a DEAE column, its electronegative charge being the proposed mechanism. In the mouse tail-bleeding model, oral pollen extract significantly shortened bleeding but the acidic polysaccharide fraction alone did not - so the external and oral haemostatic actions of this drug depend on different constituents. This is the primary source for the factor XII mechanism.

doi:10.1097/MBC.0b013e328349a22c

Evaluation of VEGF mediated pro-angiogenic and hemostatic effects and chemical marker investigation for Typhae Pollen and its processed product

Gao M, Ge Z, Deng R, Bao B, Yao W, Cao Y, Shan M, Cheng F, Yan H, Chen P, Zhang L · Journal of Ethnopharmacology · 2021 · animal

In vitro / animal · Verified

Raw and carbonised Typhae Pollen were compared by UPLC-QTOF-MS and in two zebrafish models. 19 compounds were identified; flavonoid glycosides fell markedly on carbonisation while quercetin, isorhamnetin and kaempferol rose about 30 percent, and huaicarbon A and B appeared only in the charred product. Raw pollen promoted angiogenesis via VEGFA, flt1 and kdr upregulation; carbonisation reduced that activity and enhanced haemostasis via VEGFA and von Willebrand factor. Six markers were derived for telling the two drugs apart.

doi:10.1016/j.jep.2020.113591

[Spectrum-active relation research on Typha angustifolia before and after carbonized]

Chen PD, Kong XP, Li F, Ding AW · Zhongyaocai (Journal of Chinese Medicinal Materials) · 2012 · in vitro

In vitro / animal · Not yet verified

Raw Typha angustifolia pollen and its carbonised product were compared by UPLC-MS and tested for thrombin activity. Flavonoid glycoside content fell markedly on carbonisation and the difference in thrombin activity mapped chiefly onto quercetin and isorhamnetin, supporting the flavonoids as the principals behind the drug's effect on clotting.

Pharmacological Potential and Electrochemical Characteristics of Typha angustifolia Pollen

Abadilla JMS, Chen BY, Ganzon MAD, Caparanga AR, Pamintuan KRS, Tayo LL, Hsueh CC, Hsieh CY, Yang LL, Tsai PW · Plants · 2024 · in vitro

In vitro / animal · Not yet verified

Water and ethanol extracts of Typha angustifolia pollen were profiled and assayed. The water extract carried the higher phenolic and flavonoid content, 32.6 and 31.5 mg/g respectively, and HPLC identified eleven compounds dominated by quercetin, kaempferol and isorhamnetin derivatives. Antioxidant activity was shown by DPPH and FRAP. The bioelectrochemical work in the same paper is unrelated to clinical use.

doi:10.3390/plants13202857

Safety

Contraindications

Its use is prohibited in pregnant women.

Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 213–216.

⚠ Rule-based cautions

These entries come from the deterministic rule tables that gate Verscienta's formula tools: classical pair prohibitions, pregnancy and lactation contraindications, dose ceilings, and drugs outside the Chinese Pharmacopoeia. The botanical-genus entries are different: advisory notes are not part of the safety screen; the Aristolochia genus check is.

Pregnancy

Avoid uterine stimulant (raw)

Cultural and historical

Shen Nong Ben Cao Jing · Han dynasty

Pu Huang is listed in the upper class of the earliest materia medica, for pain in the heart and abdomen and for promoting urination, alongside the breaking of stasis Blood - so both halves of its modern action set are present from the beginning.

Ben Cao Gang Mu · Ming dynasty

Li Shizhen sets out the processing rule that still governs the drug: used raw it moves Blood and dispels stasis, while charred it stops bleeding. Modern chemistry has since confirmed that carbonisation substantially changes the flavonoid profile and reverses the pharmacological emphasis.

References

  1. Liu J, Chen Z, Tao S, Shu X, Shao B, Zhang X, Yang Y, Wang X. Traditional uses and emerging therapeutic potential of Typha angustifolia L.: insights into its phytochemistry, pharmacological activities and quality control. Frontiers in Pharmacology. 2025 doi:10.3389/fphar.2025.1557136
© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice